Chicago, site of AUA's 2003 annual meeting, offers attendees and theirguests an almost endless assortment of cultural, entertainment, shopping,dining, and recreational activities to occupy their free time. Visitorsbenefit from the large range of choices found only in a big city but willfeel welcome wherever they go, thanks to Chicago's brand of Midwestern friendliness.
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.